Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
30-day Complications
33%
African American
100%
African American Patients
66%
Bad Outcomes
16%
Benign Histology
16%
Body Mass Index
33%
Cancer-specific Survival
16%
Charlson Comorbidity Index
33%
Chronic Kidney Disease
33%
Complication Rate
16%
Disease-free Survival
50%
Disease-specific Survival
16%
Early Discovery
16%
Estimated Blood Loss
33%
Estimated Glomerular Filtration Rate
33%
Fuhrman Grade
16%
High Incidence
50%
High-grade Tumor
16%
High-volume Center
16%
Imaging Studies
16%
Index Tumor
16%
Kaplan-Meier Curve
16%
Kidney Survival
16%
Laparoscopic Partial Nephrectomy
16%
Large Volume
100%
Length of Stay
33%
Low Stage
33%
Minimally Invasive Partial Nephrectomy
100%
Nephrometry Score
33%
Operative Time
33%
Overall Survival
66%
Papillary Renal Cell Carcinoma (pRCC)
33%
Partial Nephrectomy
33%
Pathological Subtype
16%
Racial Comparisons
100%
Renal Cancer
33%
Renal Mass
100%
Robotic Partial Nephrectomy
16%
Robotics
16%
Sex Body
16%
Surgical Procedures
16%
Tertiary Care Centers
100%
Tumor Characteristics
16%
Tumor Size
50%
Tumor Stage
16%
Unclassified Renal Cell Carcinoma
33%
Medicine and Dentistry
Bleeding
40%
Body Mass Index
40%
Cancer Staging
20%
Cancer Survival
20%
Charlson Comorbidity Index
40%
Chronic Kidney Disease
40%
Clear Cell Renal Cell Carcinoma
40%
Disease Free Survival
60%
Disease Specific Survival
20%
Glomerular Filtration Rate
40%
Histology
20%
Kaplan Meier Method
20%
Kidney Cancer
40%
Kidney Tumour
100%
Median Follow Up
40%
Neoplasm
80%
Overall Survival
80%
Papillary Renal Cell Carcinomas
40%
Partial Nephrectomy
100%
Surgical Technique
20%
Tumor
20%